A 6-week randomized trial found that tirzepatide significantly reduced energy intake, appetite, and cravings in adults with ...

GP in many parts of England are having explain to eligible patients that tirzepatide (Mounjaro) cannot be prescribed in ...

Three months since Suzanne Harrington was prescribed the weight-loss jab Mounjaro, she opens up her diary and reveals all ...

An injectable weight-loss treatment is now available through primary care across the UK - and general practices across ...

GLP-1 drugs like semaglutide and tirzepatide show promise in treating obesity, with benefits including weight loss and ...

Hundreds of people have reported problems with their pancreas after taking GLP-1 agonists, including ten deaths.

Three months since Suzanne Harrington was prescribed the weight-loss jab Mounjaro, she opens up her diary and reveals all ...

For the first time, 40-year-old Manmeet Bindra feels motivated to exercise and has set up a home gym, cleaned up her diet and ...

GPs fear a wave of complaints from patients hoping to access the weight-loss drug tirzepatide in primary care - amid warnings ...

People seeking weight-loss medication on the NHS are being warned it is not yet available in Derbyshire and only a very ...

India's anti-obesity drug market is currently valued at Rs 3,000-3,500 crore & is projected to grow nearly eightfold by 2030, ...

Tirzepatide has already been approved for treating obesity in Scotland by the Scottish Medicines Consortium for people with a BMI above 30kg/m² and one weight related condition. NHS Scotland are ...